Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
about
eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.Disease-dependent mechanisms of albuminuria.Imaging of the porous ultrastructure of the glomerular epithelial filtration slit.Antioxidants in kidney diseases: the impact of bardoxolone methyl.An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in RatsEmerging drugs for diabetic nephropathy.Role of remission clinics in the longitudinal treatment of CKD.Novel effective drugs for diabetic kidney disease? or not?Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects.Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.Losartan in diabetic nephropathy
P2860
Q33597090-DDEE43FE-8D3E-421B-892A-069EDB017627Q34012444-8DFD8CEF-6337-49F0-A289-CD343FE31978Q34457145-6BB856EA-65C7-49F9-B9D2-9BE8B3F830DAQ36026304-73F3D0E8-31A5-474C-9394-FC7AD2004DDCQ36232508-EDD3D5F9-17BD-4E1F-8D36-8BB56655443FQ36302838-FEF4D280-570D-4D46-B7F7-4AC452D09BBCQ36677647-D79BFF58-B5FB-451E-B6FF-516576E0AF8EQ38265818-8B5E9C27-4EBF-4517-B098-3D815C1E58D7Q42933669-0C89FFF3-C6BF-4399-985D-04F4FC641B05Q43475358-33FA2540-CDC2-4E7E-93EA-9B0879434744Q44737055-AC6B8E0A-284F-4B2B-8BAA-5A256DB2B7C3Q57703074-B2DB4F04-54C8-4084-8DF6-8B597BDACB4F
P2860
Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Glomerular size-selective dysf ...... r by calcium channel blockade.
@en
Glomerular size-selective dysf ...... r by calcium channel blockade.
@nl
type
label
Glomerular size-selective dysf ...... r by calcium channel blockade.
@en
Glomerular size-selective dysf ...... r by calcium channel blockade.
@nl
prefLabel
Glomerular size-selective dysf ...... r by calcium channel blockade.
@en
Glomerular size-selective dysf ...... r by calcium channel blockade.
@nl
P2093
P50
P1433
P1476
Glomerular size-selective dysf ...... r by calcium channel blockade.
@en
P2093
F Casiraghi
F Sangalli
P304
P356
10.1046/J.1523-1755.1999.055003984.X
P407
P577
1999-03-01T00:00:00Z
P5875
P6179
1038414553